Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-Ang2 and anti-VEGFA IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb is capable of inhibiting two proangiogenics fators and a combined blockade of them has a greater inhibitory efficacy compared with inhibition of either factor alone. It is designed for the research of Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-Ang2 x Human Anti-VEGFA Bispecific Antibody (scIgG) (SCIGG-H196). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS